Clinical Trial Update: The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intratympanic methylprednisolone injections versus placebo for vertigo attacks in Meniere's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meniere Disease

Drugs mentioned

• methylprednisolone (intrATympanic) (methylprednisolone)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Meniere Disease | Phase 3 | Status: RECRUITING